Morie Gertz

A Phase 1/2, Open Label, Dose Escalation Study Of Intravenous Administration Of Single Agent NEOD001 In Subjects With Light Chain (AL) Amyloidosis · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Hematology and Medical Oncology
Mayo Clinic College of Medicine and Science
1981–1984
Mayo Clinic College of Medicine and Science
1978–1981
Internal Medicine Presbyterian-St. Luke's Medical Center
1975–1978
Loyola University Chicago Stritch School of Medicine
1971–1975

Research

International uniform response criteria for multiple myeloma
Leukemia · 2006 · 2,240 citations
Improved survival in multiple myeloma and the impact of novel therapies
Blood · 2008 · Last of 13 authors · 1,891 citations
Review of 1027 patients with newly diagnosed multiple myeloma
Mayo Clinic Proceedings · 2003 · 1,719 citations

Angela Dispenzieri
639 papers
ML
Martha Lacy
516 papers
Shaji Kumar
504 papers · 7 as a fellow
RK
Robert Kyle
432 papers
Francis Buadi
408 papers
Suzanne Hayman
384 papers
David Dingli
379 papers
SR
Sundararajan Rajkumar
373 papers
Prashant Kapoor
341 papers
Nelson Leung
319 papers
Wilson Gonsalves
265 papers · 9 as a fellow
Taxiarchis Kourelis
259 papers · 13 as a fellow

Grants

Phase 3 Stem Cell Transplant for Light Chain Amyloidosis
National Cancer Institute · R01
Contact PI · $1.4M · Mayo Clinic Rochester
2005–2012

Clinical trials

Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Principal investigator · Completed · Phase 1, Phase 2
National Cancer Institute (NCI)
2003
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Study chair · Completed · Phase 3
Mayo Clinic
2005–2014
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Study chair · Terminated · Phase 1
Eastern Cooperative Oncology Group
2004–2011
Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Study chair · Completed · Phase 2
Eastern Cooperative Oncology Group
2000–2004